# A Pilot Study of Campath-1H Induction Therapy Combined With CellCept® Therapy to Allow for a Calcineurin Inhibitor Free Regimen After Renal Transplantation

> **NCT00214266** · PHASE2 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 31 (actual)

## Conditions studied

- Renal Transplantation

## Interventions

- **DRUG:** Campath 1H®, Rituximab, mycophenolate mofetil

## Key facts

- **NCT ID:** NCT00214266
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-08
- **Final completion:** 2007-09
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2018-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00214266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00214266, "A Pilot Study of Campath-1H Induction Therapy Combined With CellCept® Therapy to Allow for a Calcineurin Inhibitor Free Regimen After Renal Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00214266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*